Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study.

Recombinant interleukin 2 (rIL-2) and flavone acetic acid (FAA) were used to treat 34 patients with progressing metastatic melanoma. Five patients had solely non-visceral disease and the median number of organ sites involved was two. Five doses of rIL-2 were given, the first dose intrasplenically vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thatcher, N., Dazzi, H., Mellor, M., Ghosh, A., Carrington, B., Johnson, R. J., Loriaux, E. M., Craig, R. P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971351/
https://www.ncbi.nlm.nih.gov/pubmed/2331447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971351/
https://www.ncbi.nlm.nih.gov/pubmed/2331447

Ejemplares similares